Results 221 to 230 of about 23,028 (267)

Home measurement of 24-hour corticosteroid dynamics in primary aldosteronism

open access: yes
Grytaas MA   +24 more
europepmc   +1 more source

PRIMARY ALDOSTERONISM

Australasian Annals of Medicine, 1957
SUMMARYA female patient, aged thirty‐one years, suffering from primary aldosteronism due to adrenal adenoma (Conn's syndrome) is described. She presented with hypertension of the order of 240/120 millimetres of mercury associated with weakness, polyuria up to five litres a day, and an electrocardiogram showin;STdepression and prominentUwaves in various
B, HUDSON, A J, BARNETT, J, BORNSTEIN
openaire   +2 more sources

Primary Aldosteronism

Endocrinology and Metabolism Clinics of North America, 1995
The mineralocorticoid-excess state caused by primary aldosteronism usually causes hypokalemia and moderate to sever hypotension. A directed approach to the patient with suspected primary aldosteronism is essential. Appropriate use of biochemical and diagnostic imaging studies can identify the etiology of the primary aldosteronism in an efficient and ...
W R, Litchfield, R G, Dluhy
openaire   +5 more sources

Primary aldosteronism

Journal of Surgical Oncology, 2009
AbstractPrimary aldosteronism is the most common form of secondary hypertension. Case detection is based on an abnormal plasma aldosterone:plasma renin activity ratio and the diagnosis must be confirmed with an aldosterone suppression test. Subtype differentiation should be performed using adrenal venous sampling.
openaire   +4 more sources

Primary aldosteronism

The Lancet, 2002
Abstract:Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of hypertension. However, improved screening methods show that primary aldosteronism is a common form of secondary hypertension. Diagnosis of this disorder results in improved or cured hypertension or targeted pharmacotherapy. Patients with hypertension
D, Uchida, I, Tatsuno
  +7 more sources

Primary aldosteronism

Best Practice & Research Clinical Endocrinology & Metabolism, 2003
Approaching the fiftieth year since its original description, primary aldosteronism is now thought to be the commonest potentially curable and specifically treatable form of hypertension. Correct identification of patients with primary aldosteronism requires that the effects of time of day, posture, dietary sodium intake, potassium levels and ...
Stowasser, Michael, Gordon, Richard D.
openaire   +3 more sources

Primary aldosteronism

Trends in Cardiovascular Medicine, 2016
In 1955 Dr Jerome Conn first documented primary aldosteronism (PA). Since then, screening, diagnosis and treatment have developed, in the process both refining and complicating management. Currently, screening requires 4-6 weeks of lead-up, including major changes in antihypertensive therapy, followed by a blood draw for plasma aldosterone ...
openaire   +3 more sources

Primary aldosteronism

Current Cardiology Reports, 2007
Primary aldosteronism is one of the few potentially curable forms of hypertension. This article highlights recent advances in the pathophysiology, diagnosis, and treatment of this relatively common secondary form of hypertension. These topics include the recognition that this disorder is more prevalent than previously assumed, the identification of ...
Richard J, Auchus, Fiemu E, Nwariaku
openaire   +2 more sources

Subclinical primary aldosteronism

Best Practice & Research Clinical Endocrinology & Metabolism, 2012
Screening for primary aldosteronism was historically recommended in patients with moderate to severe and/or resistant hypertension. Patients with mild hypertension and normotensive subjects were therefore excluded from the screening. However, a considerable number of normotensive individuals without hypokalaemia may have subclinical forms of primary ...
Yuji, Ito   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy